Location History:
- Leiden, NL (2022)
- Vleuten, NL (2022 - 2024)
Company Filing History:
12 out of 159 
4 out of 531 
1 out of 915 
Years Active: 2022-2025
Title: Jeroen Geurtsen: A Pioneer in Immunology and Bioconjugate Technology
Introduction
Jeroen Geurtsen, an accomplished inventor based in Vleuten, Netherlands, has made a significant impact in the field of immunology and bioconjugate technology. With an impressive portfolio of 11 patents, he continues to push the boundaries of innovation, contributing to advancements in pharmaceutical compositions and immune response mechanisms.
Latest Patents
Two of Jeroen Geurtsen’s latest patents showcase his innovative spirit. The first patent focuses on FimH mutants, detailing polypeptides that include a FimH lectin domain with one or more amino acid mutations. These modifications bring the FimH lectin domain into a low affinity conformation for mannose. His research covers pharmaceutical compositions containing such polypeptides and methods aimed at stimulating immune responses in subjects requiring intervention.
The second patent pertains to the production of bioconjugates, specifically involving host cells engineered to produce a bioconjugate of an O18 antigen polysaccharide linked to a carrier protein. These host cells contain modified Wzy O-antigen polymerases, which exhibit specific amino acid substitutions that enhance yield and improve glycosylation patterns of the resulting O18 bioconjugates. The patent also describes methods for utilizing these host cells to generate compositions featuring multivalent bioconjugates.
Career Highlights
Throughout his career, Jeroen Geurtsen has collaborated with reputable companies, including Janssen Pharmaceuticals, Inc. and GlaxoSmithKline Biologicals S.A. His work in these organizations has allowed him to advance his research and develop groundbreaking technologies that benefit the pharmaceutical industry and enhance therapeutic options.
Collaborations
In his journey as an innovator, Jeroen has collaborated with notable professionals in the field, including Pieter Jan Burghout and Darren Robert Abbanat. These partnerships have fostered an environment of creativity and shared expertise, further fueling his innovations.
Conclusion
Jeroen Geurtsen's contributions to the fields of immunology and bioconjugate technology through his extensive patent portfolio highlight his dedication to scientific advancement. His remarkable innovations, combined with fruitful collaborations, continue to inspire future developments in pharmaceutical sciences.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.